… Asthma Education and Prevention Program, 2007 ; Bateman et al., 2008 ). Nonetheless,
treatment of asthma with a long-acting bronchodilator is … that long-acting bronchodilator therapy …

… The increasing burden of COPD has stimulated research into novel treatment approaches
(including new pharmacotherapies) and optimized management strategies. An international …

… of chronic obstructive pulmonary disease (COPD). The aim … , a novel anticholinergic agent
with bronchodilator properties, … for the treatment of COPD or asthma, and some were recently …

… bronchodilators in the treatment of COPD, there is still considerable interest in finding novel
classes of bronchodilator … in those with overlap between COPD and asthma [35]. Therefore, …

… that long-acting bronchodilator therapy should always be considered when patients with
COPD … once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a …

… Long-acting bronchodilators are recommended as maintenance therapy for chronic obstructive
pulmonary disease (COPD… to evaluate its potential as a novel treatment option in COPD. …

… 4,s Smoking is the most significant risk factor for the development of COPD. Other risk
factors include hereditary deficiency of oq antitrypsin, asthma and airway hyperresponsiveness, …

… Recently published have been details of a novel, highly stable, crystalline form of a formoterol
derivative as a novel LABA, including processes for its preparation, compositions …

… is a novel, inhaled, long-acting β 2 … COPD and asthma. This study assessed the dose
response, efficacy, and safety of VI at doses of 3 to 50 μg in patients with moderate to severe COPD…

… with ICS in patients with asthma. Abediterol (LAS100977) is a novel, potent and selective …
-daily treatment of chronic obstructive pulmonary disease (COPD) and asthma in combination …